Ca V 1.3 voltage-gated L-type Ca 2+ channels (LTCCs) play an important role for hearing, cardiac pacemaking and neuronal excitability. The C-terminus of Ca V 1.3 tightly controls channel gating by an intramolecular protein interaction involving two putative α-helices (termed PCRD, DCRD), which form a C-terminal modulatory mechanism (CTM) only in full-length Ca V 1.3 variants. In short (Ca V 1.3 42A and Ca V 1.3 43S ) Ca V 1.3 α1 subunit splice variants CTM is absent which leads to profound changes in channel gating: activation occurs at more negative voltages and Ca 2+ -dependent inactivation (CDI) is faster.
Background
Ca V 1.3 voltage-gated L-type Ca 2+ channels (LTCCs) play an important role for hearing, cardiac pacemaking and neuronal excitability. The C-terminus of Ca V 1.3 tightly controls channel gating by an intramolecular protein interaction involving two putative α-helices (termed PCRD, DCRD), which form a C-terminal modulatory mechanism (CTM) only in full-length Ca V 1.3 variants. In short (Ca V 1.3 42A and Ca V 1.3 43S ) Ca V 1.3 α1 subunit splice variants CTM is absent which leads to profound changes in channel gating: activation occurs at more negative voltages and Ca 2+ -dependent inactivation (CDI) is faster.
Methods
We quantified Ca V 1.3 splice variants by qPCR analysis and transcript scanning, using different mouse tissues. To assess the physiological relevance of CTM, we generated a mutant mouse strain in which CTM function is disrupted by an HA-tag (Ca V 1.3-DCRD HA/HA mice). We used anti-HA antibodies to detect the expression of the HA-tagged full length channel by Western blot analysis.
Results
The short variants Ca V 1.3 42A (highest relative abundance in substantia nigra (SN) and ventral tegmental area (VTA)) and Ca V 1.3 43S are both less abundant in mouse brain indicating that the full length form Ca V 1.3 L comprises the most abundant form (about 50% of all transcripts). In mouse heart short transcripts are rare and Ca V 1.3 L represents about 90% of all known transcripts. Ca V 1.3-DCRD HA/HA mice contain a homozygous interruption of the CTM by disrupting the DCRD helix with an HA-tag. We show that this induces "short" gating properties in this mutant full-length variant. Homozygous mice are viable and display no gross anatomical and functional abnormalities. Expression of the HA-tagged full-length channel could be detected in mouse whole brain membrane preparations. Heterozygous mice show no overt differences in locomotor activity during daytime.
Conclusions
We have successfully generated a mouse model which will enable us to study the physiological role of CTM function in vivo. It mimics the (permanent) pharmacological inhibition of CTM function and will thus allow predictions about its potential as a new drug target. Furthermore, the HA-tagged α1 subunit will provide a tool to specifically determine the expression of Ca V 1.3 L channels with anti-HA antibodies in mouse tissues.
